These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 52612)
61. Xenotransplantation and ABO incompatible transplantation: the similarities they share. Galili U Transfus Apher Sci; 2006 Aug; 35(1):45-58. PubMed ID: 16905361 [TBL] [Abstract][Full Text] [Related]
62. Silica-induced alterations of murine lymphocyte immunocompetence and suppression of B lymphocyte immunocompetence: a possible mechanism. Miller SD; Zarkower A J Reticuloendothel Soc; 1976 Jan; 19(1):47-61. PubMed ID: 177777 [No Abstract] [Full Text] [Related]
63. Genes on different chromosomes influence the antibody response to bacterial antigens. Baker PJ; Bailey DW; Fauntleroy MB; Stashak PW; Caldes G; Prescott B Immunogenetics; 1985; 22(3):269-76. PubMed ID: 2412957 [TBL] [Abstract][Full Text] [Related]
64. Clearance and re-expression of a myeloma cell's antigen-binding receptors induced by ligands known to be immunogenic or tolerogenic for normal B lymphocytes: a model to study membrane events associated with B cell tolerance. Bankert RB; Mayers GL; Pressman D Eur J Immunol; 1978 Jul; 8(7):512-9. PubMed ID: 308457 [No Abstract] [Full Text] [Related]
65. In vivo effects of cyclosporin A on murine B-cells responding to type III pneumococcal polysaccharide. Sozzani S; Sironi M; Magistrelli M; Luini W; Spreafico F; Vecchi A Int J Immunopharmacol; 1990; 12(4):359-64. PubMed ID: 2202688 [TBL] [Abstract][Full Text] [Related]
66. The immune response to the alpha 1-6 epitope of dextran is determined by a gene linked to the IgCH locus. Fernandez C; Lieberman R; Möller G Scand J Immunol; 1979; 10(1):77-80. PubMed ID: 112674 [TBL] [Abstract][Full Text] [Related]
67. Immunochemical studies on dextran-specific and levan-specific myeloma proteins from NZB mice. Wu AM; Kabat EA; Weigert MG Carbohydr Res; 1978 Oct; 66():113-24. PubMed ID: 698981 [TBL] [Abstract][Full Text] [Related]
68. Anti-alpha 1-6 epitope, specificity of a T-cell hybrid-secreted factor: affinity- and ion-exchange chromatographic separation. Pasanen VJ; Möller G Cell Immunol; 1988 Apr; 113(1):33-51. PubMed ID: 2452702 [TBL] [Abstract][Full Text] [Related]
69. Sequential activation of V genes during postnatal life. Bona CA Prog Clin Biol Res; 1981; 70():53-9. PubMed ID: 6171834 [No Abstract] [Full Text] [Related]
70. Effect of substitution on reactivity of B 512 dextran fractions with anti-B 512 dextran in heterologous passive cutaneous anaphylaxis. Richter W Int Arch Allergy Appl Immunol; 1975; 48(4):505-12. PubMed ID: 1120617 [TBL] [Abstract][Full Text] [Related]
71. The nature of drug-induced B cell tolerance. Howard JG; Shand FL Immunol Rev; 1979; 43():42-68. PubMed ID: 83289 [No Abstract] [Full Text] [Related]
72. Analysis of the interaction between an alpha (1----6)dextran-specific mouse hybridoma antibody and dextran B512 by affinity electrophoresis. Mimura Y; Nakamura K; Takeo K J Chromatogr; 1992 Apr; 597(1-2):345-50. PubMed ID: 1381368 [TBL] [Abstract][Full Text] [Related]
73. The immune response against two epitopes on the same thymus-independent polysaccharide carrier. II. Enhanced anti-hapten responses by injection of the unconjugated carrier. Fernandez C; Möller G Immunology; 1977 Sep; 33(3):331-7. PubMed ID: 71264 [TBL] [Abstract][Full Text] [Related]
74. Molecular size and structure in relation to the tolerogenicity of small fructosans (levans). Moreno C; Courtenay BM; Howard JG Immunochemistry; 1976 May; 13(5):429-35. PubMed ID: 780266 [No Abstract] [Full Text] [Related]
75. Antigenicity of dextran-protein conjugates in mice. Effect of molecular weight of the carbohydrate and comparison of two modes of coupling. Seppälä I; Mäkelä O J Immunol; 1989 Aug; 143(4):1259-64. PubMed ID: 2473126 [TBL] [Abstract][Full Text] [Related]
76. The mitogenic, immunogenic and tolerogenic properties of dextrans and levans. Lack of correlation according to differences of molecular structure and size. Moreno C; Hale C; Ivanyi L Immunology; 1977 Aug; 33(2):261-7. PubMed ID: 608689 [TBL] [Abstract][Full Text] [Related]
77. Clinical dextrans lack mitogenic activity for normal human lymphocytes in vitro. Cunnington PG; Blackshaw RM; Sykes IK Int Arch Allergy Appl Immunol; 1980; 63(2):195-200. PubMed ID: 6158483 [TBL] [Abstract][Full Text] [Related]
78. Immunochemical and related interactions with dextrans reviewed in terms of improved structural information. Jeanes A Mol Immunol; 1986 Sep; 23(9):999-1028. PubMed ID: 2431300 [TBL] [Abstract][Full Text] [Related]
79. Antigen-specific drug-targeting used to manipulate an immune response in vivo. Abu-hadid MM; Bankert RB; Mayers GL Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7232-6. PubMed ID: 2444976 [TBL] [Abstract][Full Text] [Related]
80. A new immunochemical purity test for clinical dextran. Methodology and studies on clinical dextran preparations. Richter AW Int Arch Allergy Appl Immunol; 1980; 61(4):457-66. PubMed ID: 6154016 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]